In agreement with this, prognostic analysis using the online Kaplan-Meier plotter database also indicated that OC patients with low CRAT expression had poorer overall survival (OS), although failed to reach statistical significance, and progression-free survival (PFS) than those with high CRAT expression (Fig. 1 G and H).
← all excerpts
CRAT downregulation promotes ovarian cancer progression by facilitating mitochondrial metabolism through decreasing the acetylation of PGC-1α.
1
—
—